'Next decade is likely to be a golden era' for ASX shares in this sector

This stock is expected to deliver healthy returns according to a fund manager.

| More on:
A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An investment team are very excited about the ASX healthcare share we're going to look at.

The ASX includes businesses from various healthcare sectors, including vaccine makers, private hospital operators, private health insurance providers, and device makers.

Aged care operator Regis Healthcare Ltd (ASX: REG) is one business worthy of attention, according to fund manager Blackwattle's small-cap investment team.

The company provides services to more than 9,000 older Australians through residential aged care homes, home care service hubs, day therapy and respite centres, and retirement villages.

The ASX healthcare share had a strong August, with the Regis share price increasing by 22% over the reporting season month. It reported revenue from services increased 29.9% to $1.01 billion, underlying operating profit (EBITDA) grew 28.7% to $107.2 million, and underlying net profit grew 24.7% to $35.6 million.

While the result was solid, Blackwattle is most excited about the outlook.

Improved outlook

The fund manager said the rise in the Regis Healthcare share price reflected a "significant change in the outlook for operators in the aged care industry."

Providing care and funding for aged care is a long-term issue for Australia – Blackwattle said governments have historically "kicked the can down the road for the next government to deal with".

Blackwattle then said:

But with the first baby boomers now moving into care the consequence of insufficient investment is upon us. The current government has no choice but to increase the funding of aged care operators to encourage the buildout of more beds. We believe the next decade is likely to be a golden era for aged care operators.

The Regis Healthcare share price jumped another 11% over the two days following the government's announcement that new aged care entrants will make larger means-tested contributions.

Regis is planning for growth

The ASX healthcare share expects to benefit over time from the "ageing population, improved workforce availability, additional government funding and strategic growth initiatives".

It plans to use its balance sheet and debt facility to pursue more acquisitions and greenfield development sites to grow shareholder value.

For example, in December 2023, it completed the acquisition of CPSM, which included five residential aged care homes in southeast Queensland with 644 beds for $75.2 million. The homes had an average occupancy of 97% in FY24.

The company also has a number of planned greenfield sites. The 112-bed Camberwell (VIC) site is in development, while the 123-bed Toowong (QLD) site is due to commence construction soon.

Future greenfield development locations include the 99-bed Belrose (NSW) and 101-bed Carlingford (NSW) sites, with development approval in place for both projects.

Overall, the ASX healthcare share believes there is insufficient new supply coming onto the market to meet the expected demand, which could push occupancy higher.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A male doctor wearing a white doctor's coat shrugs and holds his hands up to indicate the unimpressive CSL share price as a result of OOVID-19
Healthcare Shares

Here's the earnings forecast out to 2030 for CSL shares

How healthy will the profit growth be in the coming years?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »